Characteristic | Pravastatin group (n=34) | Placebo group (n=30) | p Value |
Predilatation | |||
MSD (mm) | 2.30 (0.08) | 2.33 (0.08) | NS |
MLD (mm) | 1.09 (0.06) | 1.12 (0.06) | NS |
RefD (mm) | 2.71 (0.09) | 2.71 (0.10) | NS |
Postdilatation | |||
MSD (mm) | 2.56 (0.07) | 2.61 (0.08) | NS |
MLD (mm) | 1.91 (0.07) | 1.97 (0.07) | NS |
RefD (mm) | 2.78 (0.08) | 2.83 (0.09) | NS |
Follow up | |||
MSD (mm) | 2.49 (0.07) | 2.58 (0.09) | NS |
MLD (mm) | 1.73 (0.08) | 1.83 (0.08) | NS |
RefD (mm) | 2.77 (0.08) | 2.80 (0.10) | NS |
Net gain | |||
MSD (mm) | 0.19 (0.05) | 0.28 (0.09) | NS |
MLD (mm) | 0.63 (0.07) | 0.73 (0.09) | NS |
Values are mean (SEM).
MLD, minimum lumen diameter; MSD, mean segment diameter; RefD, reference diameter.